Similar to hematopoietic stem cells (HSCs), SSCs are housed within the bone microenvironment; however, unlike HSCs, currently there is a lack of universally accepted cell surface markers that can be used to prospectively identity SSCs1,2,3. However, in vitro culture systems and in vivo reconstitution assays demonstrate that a proportion of BMSCs have the capacity to support hematopoiesis, as well as the ability to differentiate into all cells of the mesenchymal lineages4,5. Thus, while BMSCs represent a highly heterogeneous population, a proportion of these cells have features of bona fide stem cells, as defined by their ability to self-renew and reconstitute all cells of their tissue of origin. Moreover, unlike the use of cell surface markers, BMSCs can be quickly isolated based on their rapid adherence to tissue culture plastic6,7. For these reasons, BMSCs are often used as a surrogate for SSCs5.
While preferential adherence to tissue culture (TC) plastic has been used to successfully isolate BMSCs from human tissue, murine models present additional challenges for this method. Most notably, as murine hematopoietic cells have the capacity to adhere to both TC plastic and to BMSCs, high hematopoietic contamination occurs in this model system, thus hindering the interpretation of the data generated using this isolation method6.
Notably, BMSCs reside in the bone microenvironment where oxygen tensions range from 1%-4%8. However, under standard tissue culture conditions, cell culture incubators are maintained at atmospheric oxygen levels of 21%, representing supraphysiological levels. Highlighting the functional significance of these differences, culturing cells of mesenchymal origins at 21% oxygen is associated with increased cell death9,10. Moreover, we have recently demonstrated that hematological cells and mesenchymal cells differentially respond to low oxygen tensions. Specifically, there is a substantial decrease in the numbers of CD45+ hematopoietic cells when BMSCs cultures are maintained at low oxygen tensions. Indeed, we noted a 90% reduction in CD45+ hematopoietic cells using this technique11.
Here, we share a protocol that can be easily implemented for labs to significantly reduce hematopoietic contamination and to improve the purity of mesenchymal cells during routine culture of BMSCs.